We are thrilled to announce a novel endeavor in the field of veterinary medicine—the launch of Veterinary Oncology, a new scientific journal from the Springer Nature family.
In recent years, there has been a profound surge in the recognition of cancer as a significant health concern among our companion animals, as well as the value of comparative oncology as a valuable tool in cancer research. As our understanding of veterinary oncology deepens, so too does the need for a dedicated platform to disseminate cutting-edge research, share clinical insights, and foster collaboration among veterinary professionals and others working in cancer research worldwide. Veterinary Oncology emerges as a response to this need, poised to serve as a premier platform for scholarly discourse and innovation in veterinary cancer care.
At Veterinary Oncology we pledge to uphold the highest standards of scientific rigor and integrity in the peer review process. We are delighted and grateful that the journal is supported by an editorial board comprising experts from diverse disciplines within veterinary medicine, ensuring a breadth of perspectives and a wealth of knowledge and experience. Through a rigorous peer-review process, we endeavor to uphold the integrity of the research published in our journal and to publish content of high value to the community.
We welcome contributions that encompass a wide array of topics within veterinary oncology. From innovative therapeutic approaches, novel diagnostic modalities to cancer epidemiology and clinical case studies, and from basic science to translational research, Veterinary Oncology seeks to encompass the full spectrum of advancements in our field. Moreover, we recognize the vital role of interdisciplinary collaboration in tackling the complex challenges posed by cancer in animals. As such, Veterinary Oncology will serve as a bridge between various disciplines, fostering dialogue and collaboration among researchers, clinicians, and industry professionals.
In the first papers published this month, you will find new research pertaining to biomarkers of perfusion using histology and imaging techniques in dogs with head and neck cancers, as well as interesting new insight through a report of a synchronous canine meningioma and pituitary macroadenoma.
We invite you to join us in this endeavor, as we work together to shape the future of veterinary oncology.
With warm regards,
Amy LeBlanc & David Killick
Co-Editors-in-Chief, Veterinary Oncology
Author information
Authors and Affiliations
Contributions
The author(s) read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
LeBlanc, A., Killick, D. Welcome to Veterinary Oncology. Vet. Oncol. 1, 1 (2024). https://doi.org/10.1186/s44356-024-00003-2
Published:
DOI: https://doi.org/10.1186/s44356-024-00003-2